<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Antimicrobial regimens for odontogenic soft tissue infections in adults*&lt;sup&gt;¶&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Antimicrobial regimens for odontogenic soft tissue infections in adults*<sup>¶</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Antimicrobial regimens for odontogenic soft tissue infections in adults*<sup>¶</sup></div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">Patient population</td> <td class="subtitle1">Common causative organisms</td> <td class="subtitle1">Antimicrobial regimens<sup>Δ</sup></td> </tr> <tr> <td rowspan="6"><strong>Immunocompetent patients</strong></td> <td rowspan="6"><em>Viridans</em> and other streptococci, <em>Peptostreptococcus</em> spp, <em>Bacteroides</em> spp, and other oral anaerobes</td> <td>Ampicillin-sulbactam 3 g IV every 6 hours <strong>OR</strong></td> </tr> <tr> <td> <p>Penicillin G 2 to 4 million units IV every 4 to 6 hours</p> <p><strong>PLUS</strong></p> Metronidazole 500 mg IV or PO every 8 hours <strong>OR</strong></td> </tr> <tr> <td>Cefoxitin 2 g IV every 6 hours <strong>OR</strong></td> </tr> <tr> <td>Cefotetan 2 g IV every 12 hours <strong>OR</strong></td> </tr> <tr> <td> <p>Ceftriaxone 2 g IV every 24 hours</p> <p><strong>PLUS</strong></p> Metronidazole 500 mg IV or PO every 8 hours <strong>OR</strong></td> </tr> <tr> <td> <p>Metronidazole 500 mg IV or PO every 8 hours<sup>◊</sup></p> <p><strong>PLUS</strong></p> Levofloxacin 750 mg IV or PO every 24 hours</td> </tr> <tr class="highlight_lght_gray_text"> <td rowspan="4"><strong>Immunocompromised patients</strong></td> <td rowspan="4"><em>Viridans</em> and other streptococci, <em>Peptostreptococcus</em> spp, <em>Bacteroides</em> spp, and other oral anaerobes, facultative gram-negative bacilli (including <em>Pseudomonas aeruginosa</em>)</td> <td>Piperacillin-tazobactam 4.5 g IV every 6 hours <strong>OR</strong></td> </tr> <tr class="highlight_lght_gray_text"> <td> <p>Cefepime 2 g IV every 12 hours</p> <p><strong>PLUS</strong></p> Metronidazole 500 mg IV or PO every 8 hours <strong>OR</strong></td> </tr> <tr class="highlight_lght_gray_text"> <td>Meropenem 1 g IV every 8 hours <strong>OR</strong></td> </tr> <tr class="highlight_lght_gray_text"> <td> <p>Levofloxacin 750 mg IV or PO every 24 hours<sup>¶</sup></p> <p><strong>PLUS</strong></p> Metronidazole 500 mg IV or PO every 8 hours</td> </tr> </tbody></table></div><div class="graphic_lgnd">For patients with local soft tissue odontogenic infections, antimicrobial therapy is generally indicated if the patient has fever or regional lymphadenopathy, or if infection has perforated the bony cortex and spread into surrounding soft tissue. Refer to other UpToDate content on management of patients with odontogenic deep neck space infections.</div><div class="graphic_footnotes"><p>IV: intravenous; MRSA: methicillin-resistant <em>Staphylococcus aureus</em>; PO: by mouth.</p>
<p>* The doses recommended in this table are intended for patients with normal renal and hepatic function.</p>
<p>¶ Local and institutional rates of antibiotic resistance should be considered before choosing an antibiotic regimen. This is particularly important for immunocompromised patients, since there are substantial rates of fluoroquinolone resistance among <em>Pseudomonas aeruginosa</em> and other gram-negative bacteria in some regions.</p>
<p>Δ For patients with risk factors for MRSA infection, we typically add vancomycin (or other MRSA-active antibiotic) to the initial empiric regimen.</p>
◊ This is an option for immunocompetent patients with penicillin allergy. Meropenem is another option, depending on the type of allergy.</div><div id="graphicVersion">Graphic 70669 Version 13.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
